1
|
Patel SA, Gerber WK, Zheng R, Khanna S, Hutchinson L, Abel GA, Cerny J, DaSilva BA, Zhang TY, Ramanathan M, Khedr S, Selove W, Woda B, Miron PM, Higgins AW, Gerber JM. Natural history of clonal haematopoiesis seen in real-world haematology settings. Br J Haematol 2024; 204:1844-1855. [PMID: 38522849 DOI: 10.1111/bjh.19423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2023] [Revised: 03/08/2024] [Accepted: 03/13/2024] [Indexed: 03/26/2024]
Abstract
Recursive partitioning of healthy consortia led to the development of the Clonal Hematopoiesis Risk Score (CHRS) for clonal haematopoiesis (CH); however, in the practical setting, most cases of CH are diagnosed after patients present with cytopenias or related symptoms. To address this real-world population, we characterize the clinical trajectories of 94 patients with CH and distinguish CH harbouring canonical DNMT3A/TET2/ASXL1 mutations alone ('sole DTA') versus all other groups ('non-sole DTA'). TET2, rather than DNMT3A, was the most prevalent mutation in the real-world setting. Sole DTA patients did not progress to myeloid neoplasm (MN) in the absence of acquisition of other mutations. Contrastingly, 14 (20.1%) of 67 non-sole DTA patients progressed to MN. CHRS assessment showed a higher frequency of high-risk CH in non-sole DTA (vs. sole DTA) patients and in progressors (vs. non-progressors). RUNX1 mutation conferred the strongest risk for progression to MN (odds ratio [OR] 10.27, 95% CI 2.00-52.69, p = 0.0053). The mean variant allele frequency across all genes was higher in progressors than in non-progressors (36.9% ± 4.62% vs. 24.1% ± 1.67%, p = 0.0064). This analysis in the post-CHRS era underscores the natural history of CH, providing insight into patterns of progression to MN.
Collapse
Affiliation(s)
- Shyam A Patel
- Division of Hematology/Oncology, Department of Medicine, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
- Center for Clinical and Translational Science, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - William K Gerber
- Division of Hematology/Oncology, Department of Medicine, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - Rena Zheng
- Division of Hematology/Oncology, Department of Medicine, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - Shrinkhala Khanna
- Division of Hematology/Oncology, Department of Medicine, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - Lloyd Hutchinson
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - Gregory A Abel
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
| | - Jan Cerny
- Division of Hematology/Oncology, Department of Medicine, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
- Center for Clinical and Translational Science, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - Brandon A DaSilva
- Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
| | - Tian Y Zhang
- Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
- Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California, USA
| | - Muthalagu Ramanathan
- Division of Hematology/Oncology, Department of Medicine, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
- Center for Clinical and Translational Science, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - Salwa Khedr
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - William Selove
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - Bruce Woda
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - Patricia M Miron
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - Anne W Higgins
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
| | - Jonathan M Gerber
- Division of Hematology/Oncology, Department of Medicine, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts, USA
- Center for Clinical and Translational Science, UMass Chan Medical School, Worcester, Massachusetts, USA
| |
Collapse
|
2
|
Patel SA, Cerny J, Gerber WK, Ramanathan M, Ediriwickrema A, Tanenbaum B, Hutchinson L, Meng X, Flahive J, Barton B, Gillis‐Smith AJ, Suzuki S, Khedr S, Selove W, Higgins AW, Miron PM, Simin K, Woda B, Gerber JM. Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions. EJHaem 2023; 4:1059-1070. [PMID: 38024632 PMCID: PMC10660125 DOI: 10.1002/jha2.791] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/10/2023] [Revised: 09/01/2023] [Accepted: 09/04/2023] [Indexed: 12/01/2023]
Abstract
TP53 aberrations constitute the highest risk subset of myelodysplastic neoplasms (MDS) and acute myeloid leukemia (AML). The International Consensus Classification questions the blast threshold between MDS and AML. In this study, we assess the distinction between MDS and AML for 76 patients with TP53 aberrations. We observed no significant differences between MDS and AML regarding TP53 genomics. Median overall survival (OS) was 223 days for the entire group, but prognostic discrimination within subgroups showed the most inferior OS (46 days) for AML with multihit allelic state plus TP53 variant allele frequency (VAF) > 50%. In multivariate analysis, unadjusted Cox models revealed the following variables as independent risk factors for mortality: AML (vs. MDS) (hazard ratio [HR]: 2.50, confidence interval [CI]: 1.4-4.4, p = 0.001), complex karyotype (HR: 3.00, CI: 1.4-6.1, p = 0.003), multihit status (HR: 2.30, CI 1.3-4.2, p = 0.005), and absence of hematopoietic cell transplant (HCT) (HR: 3.90, CI: 1.8-8.9, p = 0.0009). Clonal dynamic modeling showed a significant reduction in TP53 VAF with front-line hypomethylating agents. These findings clarify the impact of specific covariates on outcomes of TP53-aberrant myeloid neoplasms, irrespective of the diagnosis of MDS versus AML, and may influence HCT decisions.
Collapse
Affiliation(s)
- Shyam A. Patel
- Division of Hematology and Oncology, Department of MedicineUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Jan Cerny
- Division of Hematology and Oncology, Department of MedicineUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - William K. Gerber
- Division of Hematology and Oncology, Department of MedicineUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Muthalagu Ramanathan
- Division of Hematology and Oncology, Department of MedicineUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Asiri Ediriwickrema
- Institute for Stem Cell Biology & Regenerative Medicine; Division of Hematology, Department of MedicineStanford UniversityStanfordCaliforniaUnited States
| | - Benjamin Tanenbaum
- Division of Hematology and Oncology, Department of MedicineUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Lloyd Hutchinson
- Department of PathologyUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Xiuling Meng
- Department of PathologyUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Julie Flahive
- Department of Population & Quantitative Health SciencesUMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Bruce Barton
- Department of Population & Quantitative Health SciencesUMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Andrew J. Gillis‐Smith
- Division of Hematology and Oncology, Department of MedicineUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Sakiko Suzuki
- Division of Hematology and Oncology, Department of MedicineUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Salwa Khedr
- Department of PathologyUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - William Selove
- Department of PathologyUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Anne W. Higgins
- Department of PathologyUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Patricia M. Miron
- Department of PathologyUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Karl Simin
- Dept. of MolecularCell & Cancer BiologyUMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Bruce Woda
- Department of PathologyUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| | - Jonathan M. Gerber
- Division of Hematology and Oncology, Department of MedicineUMass Memorial Medical Center, UMass Chan Medical SchoolWorcesterMassachusettsUnited States
| |
Collapse
|
3
|
DeFazio MW, Selove W, Watts G, Harchandani S, Sood R, Lou F, Most MJ. Recurrent Giant Cell Tumor of Bone with New Pulmonary Metastases 9 Years After En Bloc Distal Radius Resection: A Case Report. JBJS Case Connect 2023; 13:01709767-202309000-00060. [PMID: 37590401 DOI: 10.2106/jbjs.cc.23.00121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/19/2023]
Abstract
CASE A 31-year-old man with a history of giant cell tumor of bone (GCTB) in the distal radius presents to clinic 9 years after en bloc distal radius resection. He was found to have a new soft tissue mass consistent with GCTB and new pulmonary metastases. Ultimately, he underwent excision of his soft tissue recurrence and partial lobectomy for his lung metastases. CONCLUSION This case highlights the importance of having a high level of suspicion for local recurrence or metastasis, even years after wide resection and negative margins.
Collapse
Affiliation(s)
- Matthew W DeFazio
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts
| | - William Selove
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts
| | - George Watts
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts
| | - Sonali Harchandani
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts
| | - Rahl Sood
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts
| | - Feiran Lou
- Department of Pathology, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts
| | - Mathew J Most
- Department of Orthopedic Oncology, Department of Orthopedic Surgery, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, Massachusetts
| |
Collapse
|
4
|
Selove W, Hutchinson L, Makarenko V, Meng X, Tomaszewicz K, Ramanathan M, Cerny J, Nath R, Chen B, Woda B, Bledsoe JR. Impact of pretransplant mutation status on survival after allogeneic stem cell transplant for acute myeloid leukemia. eJHaem 2021; 2:514-519. [PMID: 35844698 PMCID: PMC9175694 DOI: 10.1002/jha2.260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/11/2021] [Revised: 06/27/2021] [Accepted: 06/30/2021] [Indexed: 11/24/2022]
Affiliation(s)
- William Selove
- Department of Pathology UMass Memorial Medical Center University of Massachusetts Worcester Massachusetts USA
| | - Lloyd Hutchinson
- Department of Pathology UMass Memorial Medical Center University of Massachusetts Worcester Massachusetts USA
| | - Vladislav Makarenko
- Department of Pathology UMass Memorial Medical Center University of Massachusetts Worcester Massachusetts USA
| | - Xiuling Meng
- Department of Pathology UMass Memorial Medical Center University of Massachusetts Worcester Massachusetts USA
| | - Keith Tomaszewicz
- Department of Pathology UMass Memorial Medical Center University of Massachusetts Worcester Massachusetts USA
| | - Muthalagu Ramanathan
- Department of Hematology‐Oncology UMass Memorial Medical Center University of Massachusetts Worcester Massachusetts USA
| | - Jan Cerny
- Department of Hematology‐Oncology UMass Memorial Medical Center University of Massachusetts Worcester Massachusetts USA
| | - Rajneesh Nath
- Department of Hematology Medical Oncology Banner MD Anderson Cancer Center Clinic Gilbert Arizona USA
| | - Benjamin Chen
- Bristol Myers Squibb Company Cambridge Massachusetts USA
| | - Bruce Woda
- Department of Pathology UMass Memorial Medical Center University of Massachusetts Worcester Massachusetts USA
| | - Jacob R. Bledsoe
- Department of Pathology UMass Memorial Medical Center University of Massachusetts Worcester Massachusetts USA
| |
Collapse
|
5
|
Selove W, Picarsic J, Swerdlow SH. Langerin staining identifies most littoral cell angiomas but not most other splenic angiomatous lesions. Hum Pathol 2018; 83:43-49. [PMID: 30130631 DOI: 10.1016/j.humpath.2018.08.012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/24/2018] [Accepted: 08/10/2018] [Indexed: 12/26/2022]
Abstract
Although littoral cell angiomas (LCAs) are phenotypically well characterized, the antibodies used to support the diagnosis identify many other cells in the normal spleen, and some may be found in other angiomatous lesions. Based on a langerin/CD207+ LCA index case, langerin and other selected immunohistochemical staining was performed on 10 LCAs, 20 other splenic angiomatous lesions, and 7 reactive lymph nodes to further investigate the role of langerin as a diagnostic tool. Ninety percent (9/10) of LCAs were langerin positive, whereas only 1 (5%) of 20 other splenic vascular lesions was partially positive (P < .00001). All LCAs were CD1a-, CD68+, CD34-, and CD8-; 20% were S100+, 70% CD21+, and 90% cyclin D1+. Ultrastructural studies of one LCA did not show Birbeck-type granules in definite lining cells. Sinus lining cells in 7 of 7 reactive lymph nodes showed partial langerin positivity, and 4 of 4 showed partial cyclin D1 positivity. In conclusion, langerin staining is an easily interpreted and highly sensitive and specific (sensitivity [0.90], specificity [0.95]) ancillary study to help distinguish LCA from other vascular tumors of the spleen. Whether this represents cross-reactivity or true CD207 expression is uncertain, as other immunohistochemical and ultrastructural studies do not support a Langerhans cell origin. The cyclin D1 staining seen in most LCA would be consistent with their expression of other selected vascular and histiocytic markers. The similar staining pattern in some lymph node sinus lining cells suggests a possible similar cell of origin, although LCA of lymph nodes is not described.
Collapse
Affiliation(s)
- William Selove
- Division of Hematopathology, UPMC Presbyterian, Pittsburgh, PA 15213, USA.
| | - Jennifer Picarsic
- Department of Pathology, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA.
| | - Steven H Swerdlow
- University of Pittsburgh School of Medicine, UPMC Presbyterian, Pittsburgh, PA 15213, USA.
| |
Collapse
|
6
|
Selove W, Rao LV. Performance of rapid SOFIA Influenza A+B test compared to Luminex x-TAG respiratory viral panel assay in the diagnosis of influenza A, B, and subtype H3. J Investig Med 2016; 64:905-7. [PMID: 26911275 PMCID: PMC4819670 DOI: 10.1136/jim-2016-000055] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/27/2016] [Indexed: 11/25/2022]
Abstract
Influenza is an acute respiratory illness caused by influenza A or B viruses that occur in outbreaks, mainly during the winter season. Rapid laboratory diagnosis of influenza can help guide the clinical management of suspected patients effectively. Clinical sensitivities and specificities of the rapid influenza diagnostic tests have varied considerably in the literature. Most of these studies are evaluated using previously frozen or stored specimens that had previously tested positive. This study compares the performance of the rapid SOFIA Influenza A+B test to nucleic acid multiplex test x-TAG respiratory viral panel (RVP) assay in freshly collected nasal aspirates and measured simultaneously by both assays. Retrospective data from 1649 nasal aspirates (September 2014 to May 2015) collected from adults as well as from children tested simultaneously by both rapid SOFIA Influenza A+B FIA immunofluorescence (Quidel, San Diego, CA) and qualitative nucleic acid multiplex RVP assay X-TAG Luminex technology (Luminex, Austin, Texas, USA) were analyzed. Concordance, and analytical sensitivity and specificity were evaluated for influenza A, subtypes H1 and H3, and influenza B. Prevalence for influenza A by RVP was 15%, for subtype H3 it was 11.2%, and for influenza B, 2.9%. None of the aspirates were positive for influenza A subtype H1. SOFIA Influenza rapid test demonstrated good specificity and low sensitivity compared with a nucleic acid test for influenza A, subtype H3, and for influenza B. SOFIA Influenza A + B test performed well in providing a rapid diagnosis, however, confirmatory molecular testing is recommended for negative test results. Re-evaluation of test performance should be periodically carried out during outbreaks with the emergence and circulation of new influenza strains.
Collapse
Affiliation(s)
- W Selove
- Department of Pathology, UMass Memorial Medical Center, Worcester, Massachusetts, USA
| | - L V Rao
- Department of Pathology, UMass Memorial Medical Center, Worcester, Massachusetts, USA
| |
Collapse
|
7
|
Stockl T, Kwan L, Bradford L, Zweizig S, Selove W, Liu Y. Accuracy of Frozen Section in the Diagnosis of Gynecological Tumors: 5 Years of Experience from a Tertiary Center. Gynecol Oncol 2015. [DOI: 10.1016/j.ygyno.2015.09.066] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
8
|
Alexopoulos T, Antoniazzi L, Arenton M, Ballagh HC, Bingham H, Blankman A, Block M, Boden A, Bonomi G, Borodin SV, Budagov J, Cao ZL, Cataldi G, Chen TY, Clark K, Cline D, Conetti S, Cooper M, Corti G, Cox B, Creti P, Dukes EC, Durandet C, Elia V, Erwin AR, Evangelista E, Fortney L, Golovatyuk V, Gorini E, Grancagnolo F, Hagan-Ingram K, Haire M, Hanlet P, He M, Introzzi G, Jenkins M, Jennings J, Judd D, Kononenko W, Kowald W, Lau K, Lawry T, Ledovskoy A, Liguori G, Lys J, Mazur PO, McManus A, Misawa S, Mo G, Murphy CT, Nelson K, Panareo M, Pogosian V, Ramachandran S, Recagni M, Rhoades J, Segal J, Selove W, Smith RP, Spiegel L, Sun JG, Tokar S, Torre P, Trischuk J. Search for the Flavor Changing Neutral Current Decay D0--> micro+ micro- in 800 GeV Proton-Silicon Interactions. Phys Rev Lett 1996; 77:2380-2383. [PMID: 10061939 DOI: 10.1103/physrevlett.77.2380] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
9
|
Alexopoulos T, Antoniazzi L, Arenton M, Ballagh C, Bingham H, Blankman A, Block M, Boden A, Borodin S, Budagov J, Cao Z, Cataldi G, Chen T, Clark K, Cline D, Conetti S, Cooper M, Corti G, Cox B, Creti P, Dukes E, Durandet C, Elia V, Erwin A, Fortney L, Golovatyuk S, Gorini E, Grancagnolo F, Haire M, Hanlet P, He M, Introzzi G, Jenkins M, Jennings J, Judd D, Kaeding T, Kononenko W, Kowald W, lanza A, Lau K, Liguori G, Lys J, Mazur P, McManus A, Misawa S, Mo G, Murphy T, Nelson K, Newcomer M, Panareo M, Ramachandran S, Recagni M, Rhoades J, Segal J, Selove W, Smith R, Spiegel L, Sun J, Tokar S, Torre P, Trischuk J, Trojak T, Tsyganov E, Turnbull L, VanBerg R, Wagoner D, Wang C, Wang H, Wei C, Yang W, Yao N, Zhang N, Zhang S, Zou B. Effects of high energy protons on the E771 silicon microstrip detector. Radiat Phys Chem Oxf Engl 1993 1993. [DOI: 10.1016/0969-806x(93)90083-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
10
|
Naudet C, Corcoran M, Johns K, Miettinen HE, Rice J, Roberts JB, Arenton MW, Ditzler WR, Fields TH, Harrison M, Kanofsky A, Gustafson R, Cormell L, Dris M, Fleischman J, Gardella E, Kononenko W, Robinson B, Selove W, Theodosiou G, Yost B, Chen HF, Erwin AR, Hasan MA, Kuehn CE, Nelson KS, Thompson MA. Evidence for higher-twist effects in hard pi p collisions at 200 GeV/c. Phys Rev Lett 1986; 56:808-811. [PMID: 10033291 DOI: 10.1103/physrevlett.56.808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
11
|
Arenton MW, Chen HF, Corcoran M, Cormell L, Ditzler WR, Dris M, Erwin AR, Fields T, Fleischman J, Gardella E, Gustafson R, Harrison M, Hasan MA, Hitzman C, Johns K, Kanofsky A, Kononenko W, Kuehn CE, Miettinen HE, Naudet C, Nelson KS, Rice J, Roberts J, Robinson B, Selove W, Theodosiou G, Thompson MA, Yost B. Measurement of the dijet cross section in 400-GeV/c pp interactions. Phys Rev D Part Fields 1985; 31:984-995. [PMID: 9955788 DOI: 10.1103/physrevd.31.984] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|
12
|
|
13
|
Poirier JA, Biswas NN, Cason NM, Derado I, Kenney VP, Shephard WD, Synn EH, Yuta H, Selove W, Ehrlich R, Baker AL. Reactionπ−p→π−π+nat8 GeVc. ACTA ACUST UNITED AC 1967. [DOI: 10.1103/physrev.163.1462] [Citation(s) in RCA: 69] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
14
|
|
15
|
|
16
|
|
17
|
Selove W. Our Nuclear Future
. Facts, dangers and opportunities. Edward Teller and Albert L. Latter. Criterion Books, New York, 1958. 184 pp. Illus. $3.50. Science 1958. [DOI: 10.1126/science.127.3305.1042.b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Affiliation(s)
- W. Selove
- Department of Physics, University of Pennsylvania
| |
Collapse
|
18
|
|
19
|
Selove W. Atomic and Nuclear Physics
. Robert S. Shankland. Macmillan, New York, 1955. xv + 529 pp. Illus. $7.75. Science 1955. [DOI: 10.1126/science.122.3169.563.c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Affiliation(s)
- W. Selove
- Physics Department, Harvard University
| |
Collapse
|
20
|
Selove W. Angular Distribution of Pickup Deuterons for 95-Mev Protons on Carbon, and Implications as to Internal Interactions in Carbon. ACTA ACUST UNITED AC 1955. [DOI: 10.1103/physrev.98.208] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
21
|
|
22
|
|
23
|
|
24
|
|